NCT06741644 2026-04-15A Phase I/II Study of CS2009 in Participants With Advanced Solid TumorsCStone PharmaceuticalsPhase 1/2 Recruiting660 enrolled
NCT05083481 2026-04-08A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid TumorsAstellas Pharma IncPhase 1/2 Active not recruiting226 enrolled